Pricing Log in Create free account

Lipocine Inc. (LPCN) vs Psyence Biomedical Ltd. (PBM)

Lipocine Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Lipocine Inc. is the larger, with a market value of $12.6M against $11.2M — 1.1× the size. Lipocine Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Psyence Biomedical Ltd. has the higher net margin (0.00% vs −249.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Psyence Biomedical Ltd. leads on 8 and Lipocine Inc. on 3.

Valuation

Metric LPCN PBM Biotechnology median
P/E n/m 0.13 10.26
P/S 3.37 n/m 9.18
P/B 0.60 0.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.58 1.91 0.65
EV/Sales (1.58) n/m 8.98
Earnings yield (88.89%) 759.84% (34.89%)
Free cash flow yield (80.16%) (1,147.64%) (24.52%)

Profitability

Metric LPCN PBM Biotechnology median
Gross margin 100.00% — 65.16%
Operating margin (269.05%) — 0.00%
Net margin (249.16%) 0.00% 0.00%
Free cash flow margin (267.37%) 0.00% 0.00%
Return on equity (52.86%) (23.52%) (50.12%)
Return on assets (47.52%) (6.74%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LPCN PBM Biotechnology median
Revenue growth (TTM) (13.36%) — 6.26%
EPS growth (last fiscal year) (93,988.89%) (138.35%) 29.88%
Revenue growth, 5-year CAGR 64.32% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LPCN PBM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.36 8.09 4.89
Net debt to EBITDA 1.42 1.20 1.01

Dividend

Metric LPCN PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LPCN PBM Biotechnology median
Market cap 12.61m 11.21m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack